John H. Heinzerling, MD - Cancer ...

Dr. John H. Heinzerling

Claim this profile

Carolinas Medical Center/Levine Cancer Institute

Studies Lung Cancer
Studies Small Cell Lung Cancer
6 reported clinical trials
21 drugs studied

Area of expertise

1

Lung Cancer

John H. Heinzerling has run 3 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I
2

Small Cell Lung Cancer

John H. Heinzerling has run 3 trials for Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.

Carolinas Medical Center/Levine Cancer Institute

Image of trial facility.

Atrium Health Pineville/LCI-Pineville

Clinical Trials John H. Heinzerling is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

Recruiting

1 award

Phase 2 & 3

21 criteria

Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.

Recruiting

2 awards

Phase 3

14 criteria

More about John H. Heinzerling

Clinical Trial Related

9 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical Trials

Treatments John H. Heinzerling has experience with

  • Docetaxel
  • Atezolizumab
  • Cisplatin
  • Erlotinib Hydrochloride
  • Gemcitabine
  • Local Consolidation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does John H. Heinzerling specialize in?

Is John H. Heinzerling currently recruiting for clinical trials?

Are there any treatments that John H. Heinzerling has studied deeply?

What is the best way to schedule an appointment with John H. Heinzerling?

What is the office address of John H. Heinzerling?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security